Home › Compare › KPCPY vs ABBV
KPCPY yields 6.34% · ABBV yields 3.06%● Live data
📍 KPCPY pulled ahead of the other in Year 1
Combined, KPCPY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KPCPY + ABBV for your $10,000?
Kasikornbank Public Company Limited, together with its subsidiaries, provides commercial banking products and services in Thailand and internationally. The company's personal banking products and services include savings, current, fixed deposit, and foreign currency accounts; personal, home, and auto loans; debit and credit cards; life and non-life insurance products; investment products, such as mutual funds, stocks, and derivatives/futures exchange; money transfer and bill payment, cheque and draft, and foreign exchange services; and digital banking services. It also offers various products and services for small and medium enterprises, including savings, current, and fixed deposits; working capital, commercial, and special loans, as well as letters of guarantee; collection and payment services; life, non-life, and group insurance products; and import, export, and money transfer services. In addition, the company provides various products and services for corporate customers, such as cash management solutions, including current, savings, special savings deposit, and fixed deposit accounts, as well as collection, payment, liquidity management, and electronic service solutions; international trade solutions comprising import and export, global money transfer, guarantee, and trade finance solutions; working capital loans, term loans, special loans, and letters of guarantee; supply chain financing; life, non-life, and group insurance products; and foreign exchange and derivatives, corporate finance, securities, investment, and business card services. Further, it offers auto and equipment leasing, and venture capital management services. The company operates 839 branches. Kasikornbank Public Company Limited was founded in 1945 and is headquartered in Bangkok, Thailand.
Full KPCPY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.